STOCK TITAN

Brainsway Financials

BRSYF
Source SEC Filings (10-K/10-Q) Updated Jun 30, 2025 Currency USD FYE December

This page shows Brainsway (BRSYF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 8 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 76 / 100
Financial Profile 76/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth
82

Brainsway's revenue surged 29.0% year-over-year to $41.0M, reflecting rapid business expansion. This strong growth earns a score of 82/100.

Leverage
100

Brainsway carries a low D/E ratio of 0.08, meaning only $0.08 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity
100

With a current ratio of 5.19, Brainsway holds $5.19 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.

Returns
22

Brainsway generates a 4.7% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 22/100. This is up from -10.1% the prior year.

Piotroski F-Score Neutral
4/9

Brainsway passes 4 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality Cash-Backed
3.53x

For every $1 of reported earnings, Brainsway generates $3.53 in operating cash flow ($10.3M OCF vs $2.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$41.0M
YoY+29.0%
5Y CAGR+12.2%

Brainsway generated $41.0M in revenue in fiscal year 2024. This represents an increase of 29.0% from the prior year.

EBITDA
N/A
Net Income
$2.9M
YoY+169.6%

Brainsway reported $2.9M in net income in fiscal year 2024. This represents an increase of 169.6% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
N/A
Cash & Debt
$69.3M
YoY+559.2%
5Y CAGR+26.2%

Brainsway held $69.3M in cash against $4.8M in long-term debt as of fiscal year 2024.

Dividends Per Share
N/A
Shares Outstanding
38M
YoY+13.2%
5Y CAGR+11.1%

Brainsway had 38M shares outstanding in fiscal year 2024. This represents an increase of 13.2% from the prior year.

Margins & Returns

Gross Margin
N/A
Operating Margin
N/A
Net Margin
7.1%
YoY+20.3pp
5Y CAGR+51.8pp

Brainsway's net profit margin was 7.1% in fiscal year 2024, showing the share of revenue converted to profit. This is up 20.3 percentage points from the prior year.

Return on Equity
4.7%
YoY+14.8pp
5Y CAGR+47.3pp

Brainsway's ROE was 4.7% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 14.8 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

BRSYF Income Statement

Metric Q2'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q3'20 Q4'19
Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A N/A N/A N/A
Gross Profit N/A N/A N/A N/A N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses N/A N/A N/A N/A N/A N/A N/A N/A
Operating Income N/A N/A N/A N/A N/A N/A N/A N/A
Interest Expense N/A N/A N/A N/A N/A N/A N/A N/A
Income Tax N/A N/A N/A N/A N/A N/A N/A N/A
Net Income N/A N/A N/A N/A N/A N/A N/A N/A
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

BRSYF Balance Sheet

Metric Q2'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q3'20 Q4'19
Total Assets $111.6M+18.3% $94.3M+49.8% $63.0M-2.3% $64.5M-14.9% $75.7M+122.7% $34.0M-1.1% $34.4M-11.2% $38.7M
Current Assets $89.0M+11.7% $79.7M+43.6% $55.5M-4.5% $58.1M-11.2% $65.4M+169.4% $24.3M+0.9% $24.1M-16.5% $28.8M
Cash & Equivalents $67.9M-2.1% $69.3M+559.2% $10.5M-77.9% $47.6M+181.2% $16.9M-0.2% $17.0M+7.4% $15.8M-27.1% $21.7M
Inventory $4.2M-5.3% $4.4M+19.1% $3.7M-3.1% $3.8M N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $43.4M+35.7% $32.0M+49.6% $21.4M+12.1% $19.1M+3.7% $18.4M+28.0% $14.4M-0.6% $14.5M-0.3% $14.5M
Current Liabilities $25.5M+66.2% $15.3M+57.2% $9.8M+19.9% $8.1M-10.2% $9.1M+33.3% $6.8M-2.5% $7.0M+3.8% $6.7M
Long-Term Debt $5.2M+8.7% $4.8M+1908.4% $239K-5.9% $254K0.0% $254K+4.5% $243K N/A $663K
Total Equity $68.1M+9.3% $62.3M+49.9% $41.6M-8.4% $45.4M-20.8% $57.3M+192.0% $19.6M-1.4% $19.9M-17.8% $24.2M
Retained Earnings -$95.2M+3.2% -$98.4M+2.9% -$101.3M-4.3% -$97.1M-15.9% -$83.8M-8.4% -$77.3M-0.5% -$76.9M-6.9% -$71.9M

BRSYF Cash Flow Statement

Metric Q2'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q3'20 Q4'19
Operating Cash Flow N/A N/A N/A N/A N/A $1.6M N/A -$1.2M
Capital Expenditures N/A N/A N/A N/A N/A -$85K N/A $338K
Free Cash Flow N/A N/A N/A N/A N/A $1.6M N/A -$1.6M
Investing Cash Flow N/A N/A N/A N/A N/A $85K N/A -$396K
Financing Cash Flow N/A N/A N/A N/A N/A -$750K N/A -$414K
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

BRSYF Financial Ratios

Metric Q2'25 Q4'24 Q4'23 Q4'22 Q4'21 Q4'20 Q3'20 Q4'19
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets N/A N/A N/A N/A N/A N/A N/A N/A
Current Ratio 3.49-1.7 5.19-0.5 5.68-1.5 7.14-0.1 7.22+3.6 3.57+0.1 3.45-0.8 4.29
Debt-to-Equity 0.080.0 0.08+0.1 0.010.0 0.010.0 0.000.0 0.01-0.7 0.73+0.7 0.03
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Frequently Asked Questions

Brainsway (BRSYF) reported $41.0M in total revenue for fiscal year 2024. This represents a 29.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Brainsway (BRSYF) revenue grew by 29% year-over-year, from $31.8M to $41.0M in fiscal year 2024.

Yes, Brainsway (BRSYF) reported a net income of $2.9M in fiscal year 2024, with a net profit margin of 7.1%.

As of fiscal year 2024, Brainsway (BRSYF) had $69.3M in cash and equivalents against $4.8M in long-term debt.

Brainsway (BRSYF) had a net profit margin of 7.1% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

Brainsway (BRSYF) has a return on equity of 4.7% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.

Brainsway (BRSYF) generated $10.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

Brainsway (BRSYF) had $94.3M in total assets as of fiscal year 2024, including both current and long-term assets.

Brainsway (BRSYF) had 38M shares outstanding as of fiscal year 2024.

Brainsway (BRSYF) had a current ratio of 5.19 as of fiscal year 2024, which is generally considered healthy.

Brainsway (BRSYF) had a debt-to-equity ratio of 0.08 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

Brainsway (BRSYF) had a return on assets of 3.1% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

Brainsway (BRSYF) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Brainsway (BRSYF) has an earnings quality ratio of 3.53x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Brainsway (BRSYF) scores 76 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.

Back to top